Associations - Tongue Carcinoma

CHEK2 mutation CHEK2 mutation	Tongue Carcinoma Tongue Carcinoma	ABT-888 + M6620 Sensitive: C4 – Case Studies ABT-888 + M6620 Sensitive : C4
FGFR2 P253R FGFR2 P253R	Tongue Carcinoma Tongue Carcinoma	cetuximab Sensitive: C4 – Case Studies cetuximab Sensitive : C4
FGFR2 P253R FGFR2 P253R	Tongue Carcinoma Tongue Carcinoma	pazopanib Sensitive: C4 – Case Studies pazopanib Sensitive : C4
EGF expression EGF expression	Tongue Carcinoma Tongue Carcinoma	cetuximab Resistant: D – Preclinical cetuximab Resistant : D

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and